KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Cash from Financing Activities (2016 - 2025)

Astrana Health (ASTH) has disclosed Cash from Financing Activities for 15 consecutive years, with -$26.3 million as the latest value for Q4 2025.

  • Quarterly Cash from Financing Activities fell 72.51% to -$26.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $569.3 million through Dec 2025, up 321.28% year-over-year, with the annual reading at $569.3 million for FY2025, 321.28% up from the prior year.
  • Cash from Financing Activities hit -$26.3 million in Q4 2025 for Astrana Health, down from $648.5 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $648.5 million in Q3 2025 to a low of -$44.2 million in Q1 2025.
  • Historically, Cash from Financing Activities has averaged $32.0 million across 5 years, with a median of -$2.1 million in 2023.
  • Biggest five-year swings in Cash from Financing Activities: tumbled 1434.4% in 2023 and later skyrocketed 20428.87% in 2025.
  • Year by year, Cash from Financing Activities stood at $1.4 million in 2021, then surged by 309.13% to $5.9 million in 2022, then surged by 104.28% to $12.0 million in 2023, then crashed by 227.3% to -$15.3 million in 2024, then crashed by 72.51% to -$26.3 million in 2025.
  • Business Quant data shows Cash from Financing Activities for ASTH at -$26.3 million in Q4 2025, $648.5 million in Q3 2025, and -$8.6 million in Q2 2025.